Alpha-enolase: Difference between revisions
CSV import |
CSV import |
||
| Line 34: | Line 34: | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Cancer biomarkers]] | [[Category:Cancer biomarkers]] | ||
{{No image}} | |||
Revision as of 06:02, 10 February 2025
Alpha-enolase (also known as ENO1) is an enzyme that in humans is encoded by the ENO1 gene. It is one of three enolase isoenzymes found in mammals; this isoenzyme is found in most tissues in the body, and a homodimer composed of two alpha subunits constitutes the most common form.
Function
Alpha-enolase is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP), a key step in the glycolysis pathway. This reaction involves the abstraction of a proton from the 2-carbon of 2-PG to form a carbonyl group, followed by the transfer of a phosphate group from the 3-carbon to the 2-carbon to form PEP.
Clinical significance
Alpha-enolase has been identified as an autoantigen in severe forms of autoimmune diseases, such as rheumatoid arthritis and Hashimoto's encephalopathy. It is also overexpressed in several types of cancer, including lung cancer, breast cancer, and colorectal cancer, and has been suggested as a potential biomarker for these conditions.
See also
References
<references />
External links
| Enzymes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Hypersensitivity and autoimmune diseases (279.5–6) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Cancer biomarkers | ||||||||
|---|---|---|---|---|---|---|---|---|
This cancer biomarker related article is a stub.
|
